Evidence map›Paper›PMID 28029011›Full record

GuidelineAnnals of laboratory medicine2017

Clinical Pharmacogenetic Testing and Application: Laboratory Medicine Clinical Practice Guidelines.

Sollip Kim, Yeo Min Yun, Hyo Jin Chae, Hyun Jung Cho, Misuk Ji, In Suk Kim, Kyung A Wee, Woochang Lee, Sang Hoon Song, Hye In Woo and 2 more

Abstract readPractice Guideline
PubMed Full text at PMC Publisher
In one paragraph

Guideline in Annals of laboratory medicine, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Guideline
  2. Guideline
  3. Review
  4. Article
  5. [Portal Biliopathy Misdiagnosed as Hilar Cholangiocarcinoma].The Korean journal of gastroenterology = Taehan Sohwagi Hakhoe chi · 2022
    Article
  6. Knowledge, perception, and confidence of hospital pharmacists toward pharmacogenetics in Jeddah, Kingdom of Saudi Arabia.Saudi pharmaceutical journal : SPJ : the official publication of the Saudi Pharmaceutical Society · 2021
    Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Sollip KimDepartment of Laboratory Medicine, Ilsan Paik Hospital, Inje University College of Medicine, Goyang, Korea.
Yeo Min YunDepartment of Laboratory Medicine, Konkuk University Medical Center, Konkuk University School of Medicine, Seoul, Korea.
Hyo Jin ChaeDepartment of Laboratory Medicine, College of Medicine, The Catholic University of Korea, Seoul, Korea.
Hyun Jung ChoDepartment of Laboratory Medicine, Konyang University Hospital, College of Medicine, Konyang University, Daejeon, Korea.
Misuk JiDepartment of Laboratory Medicine, Veterans Health Service Medical Center, Seoul, Korea.
In Suk KimDepartment of Laboratory Medicine, School of Medicine, Pusan National University, Busan, Korea.
Kyung A WeeDepartment of Laboratory Medicine, Yonsei University College of Medicine, Seoul, Korea.
Woochang LeeDepartment of Laboratory Medicine, University of Ulsan College of Medicine and Asan Medical Center, Seoul, Korea.
Sang Hoon SongDepartment of Laboratory Medicine, Seoul National University Hospital and College of Medicine, Seoul, Korea.
Hye In WooDepartment of Laboratory Medicine, Samsung Changwon Hospital, Sungkyunkwan University School of Medicine, Changwon, Korea.
Soo Youn LeeDepartment of Laboratory Medicine and Genetics, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea. suddenbz@skku.edu.
Sail ChunDepartment of Laboratory Medicine, University of Ulsan College of Medicine and Asan Medical Center, Seoul, Korea. sailchun@amc.seoul.kr.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Pharmacogenetic testing for clinical applications is steadily increasing. Correct and adequate use of pharmacogenetic tests is important to reduce unnecessary medical costs and adverse patient outcomes. This document contains recommended pharmacogenetic testing guidelines for clinical application, interpretation, and result reporting through a literature review and evidence-based expert opinions for the clinical pharmacogenetic testing covered by public medical insurance in Korea. This document aims to improve the utility of pharmacogenetic testing in routine clinical settings.

Indexed as

AnticoagulantsAntidepressive AgentsAntimetabolites, AntineoplasticAntitubercular AgentsArylamine N-AcetyltransferaseClopidogrelCoronary Artery DiseaseCytochrome P-450 CYP2C19Cytochrome P-450 CYP2C9Cytochrome P-450 CYP2D6Depressive DisorderGenotypeIsoniazidLaboratories, HospitalMethyltransferasesPharmacogenomic TestingAnticoagulantsAntidepressive AgentsAntimetabolites, AntineoplasticAntitubercular AgentsArylamine N-AcetyltransferaseClopidogrelCytochrome P-450 CYP2C19Cytochrome P-450 CYP2C9Cytochrome P-450 CYP2D6IsoniazidMethyltransferasesNAT2 protein, humanPlatelet Aggregation Inhibitorsthiopurine methyltransferaseTiclopidineVitamin K Epoxide ReductasesVKORC1 protein, humanWarfarinClinical laboratoryKoreaPharmacogeneticsPractice guidelineTesting

Identifiers

PMID28029011
PMCPMC5204002

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.